School of Medicine
Showing 21-30 of 80 Results
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
-
Zahra Ghazi-Askar
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsBioDr. Ghazi-Askar is Assistant Professor of Emergency Medicine and, by courtesy, of Pediatrics and serves as the Director of Pediatric Ultrasound Education in the Department of Emergency Medicine . As an academic clinical educator in with expertise in pediatric and adult point-of-care ultrasound, Dr. Ghazi-Askar's clinical focus is on children and young adults who seek care in the pediatric emergency department. She is specialty-board certified in pediatric emergency medicine.
At a national level, Dr. Ghazi-Askar is the Chair of Point-of-Care Ultrasound subcommittee for the Association of Pediatric Program Directors (APPD), where she is leading the development of an educational curriculum for pediatric residency point-of-care ultrasound.
Dr. Ghazi-Askar also has expertise in the field of Tele-ultrasound, where she is able to teach point-of-care ultrasound virtually where clinical expertise may otherwise not be available. Here she is able to provide education and health equity when it is most needed. -
Ruth Margaret Gibson
Visiting Scholar, Medicine - Primary Care and Population Health
Affiliate, Pediatrics - NeonatologyBioDr. Ruth Gibson, PhD, is a scholar at Stanford University. She holds appointments at the Center for Innovation and Global Health (CIGH) and the Center for International Security and Cooperation (CISAC). Dr. Gibson’s research focuses on war, blockades, and sanctions and their impacts on maternal and child health. Her expertise is in geopolitically complex regions of the world, crises, and what all of this means for human health.
Dr. Gibson’s research is published in internationally renowned outlets such as The Lancet and The Lancet Global Health. She publishes research on issues such as foreign aid withdrawal and impacts on mothers and children, humanitarian catastrophe in Gaza, and sanctions against Iran. Her insights have been highlighted by The New York Times, The New Yorker, and TIME. Dr. Gibson responds quickly to producers, journalists, and media outlets seeking expert analysis of critical issues in war, peace, and human lives.
She is currently co-leading a Lancet Series on Global Health and Foreign Engagement with Professor Gary Darmstadt. She leads worldwide international panels on critical issues in global health – geopolitical crisis and their impacts on health – through the Consortium of Universities for Global Health (CUGH) and Stanford’s CIGH. Dr. Gibson collaborates with the United Nations High Commission for Human Rights to develop a universal monitoring system to assess the impact of sanctions on human rights. Her research has been cited in UN General Assembly meetings. She also worked on war crimes investigations with the Yale Humanitarian Research Lab and on the International Criminal Court's prosecution of war crimes.
Dr. Gibson spent a decade working internationally, engaging in humanitarian and global health initiatives across eight countries on five continents – including conflict zones. Dr. Gibson is fluent in English and proficient in Mandarin Chinese (如詩 吉布森), French, and Spanish. She holds a postdoctoral fellowship from Stanford University, a PhD from the University of British Columbia, an Honors Bachelor of Science, and a Master of Science from the University of Toronto.
Dr. Gibson can be reached at rmgibson@stanford.edu
https://drruthgibson.com/
